HIVELY BRAD (Chief Executive Officer) sold 42.0% of their position (298.85K shares) of STARLING ONCOLOGY, INC. on the open market
Open‑market sale worth $1.95M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/24/2026ACC: 0001079973-26-001175
DirectorOfficer· Chief Executive Officer
Since Nov 2021
-298.85K
Net shares
Net seller
$1.95M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
298.85K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−298.85K
Price / share
$6.51
Trade value
$1.95M
% of position
42.0%
8/21/2026
710.83K→411.98K
Total
Net shares
−298.85K
Net value
-$1.95M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/21/2026 | S · Sale | −298.85K | $6.51 | $1.95M | 42.0% | 710.83K | 411.98K |
| Total | −298.85K | -$1.95M | ||||||
Derivative Transactions0
No derivative transactions reported